The imaging chemicals market has seen considerable growth due to a variety of factors.
• There has been significant expansion in the imaging chemicals market in the last few years. The market is projected to increase from $26.63 billion in 2024 to $28.31 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. The historical growth is linked to the consumers' rising interest in photography, graphic arts and printing, medical imaging, and industrial imaging applications, along with the demand for high-quality prints and film-based cinematography.
The Imaging Chemicals market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for imaging chemicals is predicted to witness significant expansion in the coming years. The market is projected to increase to $37.57 billion by 2029, with a compound annual growth rate (CAGR) of 7.3%.
Factors contributing to this expected growth during the predicted period include the rise in printed electronics, higher demand for security imaging, the need for sustainable solutions, usage of bio-based and renewable resources, and functional imaging materials. Key trends anticipated during this period are the digital transformation of imaging, advanced photographic printing technologies, customization for specialized applications, the development of smart imaging materials, and partnerships for innovation.
The escalation in cases of cancer and brain disorders is stimulating the expansion of the imaging chemicals market. Cancer represents one of the numerous diseases distinguished by the uncontrolled multiplication of abnormal cells. Conversely, brain disorders are affiliated with diseases of both the central and peripheral nervous systems. The intensifying occurrence of these two conditions is boosting the growth of imaging chemicals. They provide distinct advantages such as live monitoring, identifying the precise stage and location of cancer, directing surgeries and additional treatment options, and offering visual representation of cellular activity. For example, the EU Science Hub, a Belgium-operated website of the European Commission's Joint Research Centre, noted in October 2023 an increase of cancer cases by 2.3% from 2020, amounting to 2.74 million in 2022. Moreover, there has been a death rate increase of 2.4% from 2010 to 2020 due to cancer. In addition, the World Federation of Neurology, a UK-based collective of national neurological societies, stated in October 2023 that brain diseases were the second leading cause of death globally and the foremost cause of disability. Therefore, the escalating incidence of cancer and brain disorders is anticipated to drive the expansion of the imaging chemicals market.
The imaging chemicals market covered in this report is segmented –
1) By Product Type: Imaging Agents And Toners, Printing Inks, Image Developers
2) By Application: Medical Diagnostics, Packaging And Printing, Textile Processing, Mining, Other Applications
Subsegments:
1) By Imaging Agents And Toners: Liquid Toners, Powder Toners, Imaging Agents For Medical Imaging
2) By Printing Inks: Solvent-Based Inks, Water-Based Inks, UV-Curable Inks, Eco-Friendly Inks
3) By Image Developers: Photographic Developers, Digital Imaging Developers, Chemical Developers For X-Ray Imaging
The key emerging trend in the imaging chemicals sector is technological innovation. In order to maintain their competitive edge in the market, top companies are pioneering advanced solutions. For example, in February 2023, Guerbet Group, a pharmaceutical and medical imaging firm based in France, introduced the Elucirem (gadopiclenol) injection. The new-generation GBCA from Guerbet provides the highest relaxivity in the magnetic resonance imaging (MRI) spectrum and is approved for use in both adults and children over two years old. Compared to traditional non-specific GBCAs, Elucirem uses half the dose of gadolinium, reducing concerns over gadolinium exposure for medical practitioners. Elucirem (Gadopiclenol) injection is used for identifying and illustrating lesions with abnormal vascular structures in the central nervous system such as the brain, spinal cord, and associated tissues, as well as in various parts of the body, including the head and neck, chest, abdomen, pelvis, and musculoskeletal system.
Major companies operating in the imaging chemicals market include:
• Eastman Kodak Company
• Agfa-Gevaert NV
• Altana AG
• BASF SE
• Clariant Chemical Company
• DIC Corporation
• Dow Chemical Company
• Flint Group S.A.
• FUJIFILM Holdings Corporation
• Hubergroup Deutschland GmbH
• Kao Corporation
• Kodak Alaris Inc.
• Qingdao Scienoc Chemical Co.
• Sakata Inx Corp.
• Siegwerk Druckfarben AG & Co. KGaA
• T&K TOKA Corporation
• Toyo Ink SC Holdings Co. Ltd.
• Wikoff Color Corporation
• Dymax Corporation
• Evonik Industries AG
• Kemira Oyj
• Merck Co. & KGaA
Asia-Pacific was the largest region in the imaging chemicals market in 2024. The regions covered in the imaging chemicals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa